Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02599636
NCT02599636UnknownNot Applicable

Multicenter Prospective Study: To Survive After ICU Discharge

Althaia Xarxa Assistencial Universitària de Manresa1 site in 1 country1,200 target enrollmentStarted: October 2015Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
1,200
Locations
1
Primary Endpoint
The decline in hospital mortality
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Many factors before and after ICU stay determine the outcome of patients at ICU discharge, the type of illness, physical dependence and other sequelae can be a trigger for complications in hospital ward which can induce ICU readmission and worse outcome. The quality of medical assistance during all the hospitalisation should be guaranteed and many complications or fatal events could be avoidable.

The objective of the present study is to demonstrate that collaboration between the intensivist and other medical teams in ward can reduce ICU readmission and hospital mortality after ICU discharge.

Detailed Description

Material and Methods This observational multicenter study will be done in 21 medical-surgical ICUs. We will use Sabadell Score like prognostic scale at ICU discharge and the intensivist will collaborate with the medical team in medical assistance of patients at risk (Sabadell Score 1 and 2). Investigators will compare the hospital mortality and the readmission rate with a previous period when this collaboration didn't exist.

Anticipate results The collaboration of attending intensivist might reduce ward mortality after ICU discharge by 3%.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All patients with Sabadell Score 1 (poor prognosis in long term) and 2 (poor prognosis in short term) at ICU discharge

Exclusion Criteria

  • •patients younger than 18 years old
  • •patients with Sabadell Score 0 (good prognosis)
  • •patients with Sabadell Score 3 (null expected survival)
  • •patients transferred to other hospitals

Outcomes

Primary Outcomes

The decline in hospital mortality

Time Frame: 3 months

Secondary Outcomes

  • The decline in number of warnings on-duty(3 months)

Investigators

Sponsor
Althaia Xarxa Assistencial Universitària de Manresa
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Silvia Cano Hernández

Physician

Althaia Xarxa Assistencial Universitària de Manresa

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
International Multicenter Study of In-hospital Outcome of Patients After ICU DischargeHospital Mortality
NCT02347150Hospital Vila Franca de Xira3,000
Recruiting
Not Applicable
Post-Resuscitation Interdisciplinary Consultation System: a Randomized, Multicenter, Interventional Study to Assess Quality of Life After a Stay in the COPRéa Intensive Care UnitPost Intensive Care Syndrome
NCT05625867Centre Hospitalier Universitaire Dijon256
Completed
Not Applicable
Prediction of Safe Discharge From ICURisk
NCT05459350Kepler University Hospital24,010
Completed
Not Applicable
Post-Intensive Care outcomeS of patients with COronaVIrus Disease 2019; PICS-COVID studyAdult coronavIrus disease 2019 patients discharged from the intensive care unit who were able to walk on their own without assistance prior to infection.
JPRN-UMIN000041276ational Hospital Organization Tokyo Medical Center410
Completed
Not Applicable
ICU Recovery in Australian PatientsIntensive Care Unit Syndrome
NCT02225938Australian and New Zealand Intensive Care Research Centre262
To Survive After ICU Discharge | Clinical Trial